Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Long Interspersed Nucleotide Elements | 26 | 2023 | 332 | 6.170 |
Why?
|
DNA Transposable Elements | 14 | 2023 | 762 | 3.860 |
Why?
|
Retroelements | 13 | 2023 | 162 | 2.030 |
Why?
|
Alu Elements | 5 | 2023 | 116 | 1.720 |
Why?
|
Interspersed Repetitive Sequences | 3 | 2020 | 52 | 0.940 |
Why?
|
Disease | 2 | 2020 | 673 | 0.840 |
Why?
|
Ovarian Neoplasms | 9 | 2023 | 4908 | 0.830 |
Why?
|
RNA-Directed DNA Polymerase | 5 | 2024 | 223 | 0.820 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 605 | 0.770 |
Why?
|
Genome, Human | 13 | 2023 | 4450 | 0.760 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2022 | 781 | 0.710 |
Why?
|
Open Reading Frames | 4 | 2017 | 812 | 0.670 |
Why?
|
Neoplasms | 13 | 2023 | 22389 | 0.670 |
Why?
|
Mutagenesis, Insertional | 5 | 2020 | 662 | 0.610 |
Why?
|
RNA Splicing | 2 | 2019 | 903 | 0.570 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2017 | 2846 | 0.530 |
Why?
|
Transcription, Genetic | 6 | 2019 | 7599 | 0.490 |
Why?
|
Reproduction | 3 | 2024 | 646 | 0.490 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3794 | 0.470 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2127 | 0.450 |
Why?
|
Gene Rearrangement | 3 | 2020 | 1139 | 0.450 |
Why?
|
VDJ Recombinases | 1 | 2013 | 84 | 0.440 |
Why?
|
Evolution, Molecular | 4 | 2024 | 1893 | 0.440 |
Why?
|
Deoxyribonuclease I | 1 | 2014 | 225 | 0.430 |
Why?
|
Leukemia, Lymphoid | 1 | 2013 | 311 | 0.430 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2038 | 0.420 |
Why?
|
Ovary | 7 | 2003 | 960 | 0.420 |
Why?
|
Genome | 3 | 2022 | 1747 | 0.410 |
Why?
|
Gonadotropins | 3 | 2003 | 241 | 0.400 |
Why?
|
Carcinoma | 1 | 2023 | 2340 | 0.400 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2003 | 161 | 0.380 |
Why?
|
RNA | 7 | 2023 | 2726 | 0.380 |
Why?
|
Genetic Loci | 3 | 2022 | 2630 | 0.380 |
Why?
|
Inhibins | 5 | 2003 | 210 | 0.370 |
Why?
|
Gene Expression | 8 | 2022 | 7595 | 0.360 |
Why?
|
Oocytes | 7 | 2005 | 1171 | 0.350 |
Why?
|
DNA | 6 | 2023 | 7211 | 0.340 |
Why?
|
Testicular Neoplasms | 4 | 2003 | 805 | 0.340 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2012 | 238 | 0.340 |
Why?
|
Germ Cells | 2 | 2012 | 643 | 0.330 |
Why?
|
Follicle Stimulating Hormone | 7 | 2005 | 726 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2022 | 2950 | 0.330 |
Why?
|
Ribonucleoproteins | 3 | 2018 | 359 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2022 | 8628 | 0.320 |
Why?
|
Software | 3 | 2020 | 4452 | 0.310 |
Why?
|
Proteins | 9 | 2023 | 6006 | 0.310 |
Why?
|
Endonucleases | 2 | 2023 | 371 | 0.300 |
Why?
|
Bone Marrow | 4 | 2023 | 2929 | 0.280 |
Why?
|
Cyclins | 3 | 2003 | 606 | 0.270 |
Why?
|
Alternative Splicing | 3 | 2020 | 1093 | 0.260 |
Why?
|
Heterochromatin | 2 | 2004 | 294 | 0.230 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2015 | 1756 | 0.230 |
Why?
|
Short Interspersed Nucleotide Elements | 3 | 2023 | 41 | 0.230 |
Why?
|
Reverse Transcription | 1 | 2023 | 48 | 0.220 |
Why?
|
Testis | 9 | 2004 | 783 | 0.220 |
Why?
|
Humans | 75 | 2024 | 768298 | 0.220 |
Why?
|
Blood Banks | 1 | 2004 | 108 | 0.210 |
Why?
|
Embryonic and Fetal Development | 2 | 2003 | 420 | 0.210 |
Why?
|
Cell Nucleolus | 1 | 2003 | 156 | 0.200 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2003 | 664 | 0.200 |
Why?
|
Genomics | 3 | 2017 | 5916 | 0.200 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2024 | 366 | 0.200 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3826 | 0.200 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5496 | 0.190 |
Why?
|
Minisatellite Repeats | 2 | 2023 | 164 | 0.190 |
Why?
|
Platelet Transfusion | 1 | 2004 | 301 | 0.180 |
Why?
|
Animals | 40 | 2024 | 169322 | 0.180 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5802 | 0.180 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 5 | 2003 | 58 | 0.180 |
Why?
|
Bone Marrow Cells | 3 | 2019 | 2414 | 0.170 |
Why?
|
Genome-Wide Association Study | 4 | 2022 | 12775 | 0.170 |
Why?
|
Ascorbic Acid | 1 | 2023 | 658 | 0.170 |
Why?
|
Mice | 31 | 2023 | 82004 | 0.170 |
Why?
|
Spermatozoa | 4 | 2009 | 631 | 0.170 |
Why?
|
Cell Cycle Proteins | 5 | 2022 | 3457 | 0.170 |
Why?
|
Translocation, Genetic | 2 | 2017 | 1395 | 0.170 |
Why?
|
Granulosa Cells | 4 | 2003 | 116 | 0.170 |
Why?
|
Base Sequence | 8 | 2015 | 12421 | 0.160 |
Why?
|
HeLa Cells | 3 | 2020 | 3092 | 0.160 |
Why?
|
Androgens | 2 | 2003 | 1285 | 0.160 |
Why?
|
Sertoli Cell Tumor | 3 | 2003 | 36 | 0.160 |
Why?
|
Embryo, Mammalian | 3 | 2003 | 1674 | 0.160 |
Why?
|
HEK293 Cells | 4 | 2022 | 4286 | 0.150 |
Why?
|
Flow Cytometry | 4 | 2020 | 5898 | 0.150 |
Why?
|
Cell Line, Tumor | 6 | 2020 | 17132 | 0.150 |
Why?
|
Mice, Knockout | 14 | 2009 | 14481 | 0.150 |
Why?
|
Integrins | 1 | 2002 | 843 | 0.150 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2019 | 248 | 0.150 |
Why?
|
RNA Splice Sites | 1 | 2019 | 212 | 0.150 |
Why?
|
Meiosis | 4 | 2009 | 327 | 0.150 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2017 | 32 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5443 | 0.140 |
Why?
|
Terminal Repeat Sequences | 1 | 2017 | 70 | 0.140 |
Why?
|
Spermatogenesis | 5 | 2008 | 259 | 0.140 |
Why?
|
Tissue Array Analysis | 2 | 2016 | 551 | 0.140 |
Why?
|
Sequence Analysis, DNA | 4 | 2020 | 4774 | 0.140 |
Why?
|
Sequence Alignment | 5 | 2014 | 2177 | 0.140 |
Why?
|
Interferon Type I | 1 | 2020 | 569 | 0.130 |
Why?
|
Organ Specificity | 5 | 2017 | 1966 | 0.130 |
Why?
|
Introns | 1 | 2019 | 968 | 0.130 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2015 | 21 | 0.130 |
Why?
|
RNA, Antisense | 1 | 2016 | 135 | 0.130 |
Why?
|
Interferons | 4 | 2023 | 717 | 0.130 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2018 | 329 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 2 | 2003 | 2811 | 0.130 |
Why?
|
Molecular Sequence Data | 11 | 2015 | 17626 | 0.130 |
Why?
|
Alleles | 2 | 2020 | 6892 | 0.130 |
Why?
|
Infertility, Male | 3 | 2009 | 397 | 0.130 |
Why?
|
Program Evaluation | 1 | 2024 | 2505 | 0.120 |
Why?
|
Esophageal Neoplasms | 2 | 2016 | 1675 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2017 | 444 | 0.120 |
Why?
|
Nerve Degeneration | 1 | 2020 | 749 | 0.120 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5800 | 0.120 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1435 | 0.120 |
Why?
|
Receptors, Estrogen | 1 | 2003 | 2247 | 0.120 |
Why?
|
Lymphoma, Primary Effusion | 1 | 2014 | 17 | 0.120 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2017 | 393 | 0.120 |
Why?
|
Cyclin D2 | 3 | 2003 | 98 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 1 | 2020 | 1131 | 0.120 |
Why?
|
Gene Expression Profiling | 5 | 2013 | 9508 | 0.120 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2014 | 79 | 0.120 |
Why?
|
Cytosine | 1 | 2015 | 213 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2018 | 480 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1501 | 0.110 |
Why?
|
Exons | 2 | 2019 | 2392 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 654 | 0.110 |
Why?
|
Embryonic Development | 2 | 2012 | 722 | 0.110 |
Why?
|
RNA, Messenger | 7 | 2019 | 12801 | 0.110 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 93 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2783 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2014 | 80 | 0.110 |
Why?
|
Cachexia | 3 | 2003 | 202 | 0.110 |
Why?
|
Automation, Laboratory | 1 | 2013 | 102 | 0.110 |
Why?
|
Nevus, Pigmented | 1 | 2015 | 221 | 0.110 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2046 | 0.110 |
Why?
|
Autoantibodies | 1 | 2021 | 2126 | 0.100 |
Why?
|
DNA Replication | 1 | 2020 | 1429 | 0.100 |
Why?
|
Ovulation | 2 | 2005 | 181 | 0.100 |
Why?
|
Female | 33 | 2024 | 397050 | 0.100 |
Why?
|
DNA Methylation | 2 | 2023 | 4419 | 0.100 |
Why?
|
Ovarian Follicle | 2 | 2005 | 244 | 0.100 |
Why?
|
Models, Genetic | 1 | 2002 | 3442 | 0.100 |
Why?
|
Cell Cycle | 5 | 2022 | 2934 | 0.100 |
Why?
|
Oogenesis | 2 | 2003 | 125 | 0.100 |
Why?
|
Linkage Disequilibrium | 1 | 2017 | 1998 | 0.100 |
Why?
|
Pathology, Clinical | 1 | 2016 | 376 | 0.100 |
Why?
|
Melanocytes | 1 | 2015 | 508 | 0.100 |
Why?
|
Autoimmunity | 1 | 2020 | 1360 | 0.100 |
Why?
|
Genome, Plant | 1 | 2012 | 84 | 0.100 |
Why?
|
Gammaretrovirus | 1 | 2011 | 24 | 0.100 |
Why?
|
Transformation, Genetic | 1 | 2012 | 194 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2015 | 494 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2474 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2013 | 628 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1885 | 0.090 |
Why?
|
Down-Regulation | 3 | 2020 | 2937 | 0.090 |
Why?
|
Genetics | 1 | 2012 | 114 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3666 | 0.090 |
Why?
|
Chromosomes, Human, Y | 1 | 2012 | 163 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.090 |
Why?
|
In Situ Hybridization | 6 | 2004 | 1905 | 0.090 |
Why?
|
DNA Restriction Enzymes | 1 | 2010 | 548 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1986 | 0.090 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 2003 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3905 | 0.080 |
Why?
|
Sepsis | 1 | 2004 | 2601 | 0.080 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1723 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2016 | 11117 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6084 | 0.080 |
Why?
|
Male | 33 | 2024 | 364870 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2014 | 617 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1111 | 0.080 |
Why?
|
Histones | 3 | 2005 | 2593 | 0.080 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 460 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2017 | 3620 | 0.080 |
Why?
|
Genetic Techniques | 1 | 2012 | 428 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2171 | 0.080 |
Why?
|
Amino Acid Sequence | 9 | 2013 | 13425 | 0.080 |
Why?
|
Cell Nucleus Structures | 1 | 2008 | 15 | 0.080 |
Why?
|
Blotting, Northern | 4 | 2002 | 1553 | 0.080 |
Why?
|
Living Donors | 1 | 2013 | 650 | 0.080 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2012 | 271 | 0.080 |
Why?
|
Chromosomes, Human, X | 1 | 2010 | 320 | 0.080 |
Why?
|
Cystinosis | 1 | 2008 | 26 | 0.080 |
Why?
|
Signal Transduction | 5 | 2020 | 23629 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1906 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1473 | 0.070 |
Why?
|
Cystine | 1 | 2008 | 93 | 0.070 |
Why?
|
Acrosome | 1 | 2007 | 10 | 0.070 |
Why?
|
Egg Proteins | 1 | 2007 | 58 | 0.070 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.070 |
Why?
|
Expressed Sequence Tags | 4 | 2016 | 250 | 0.070 |
Why?
|
Cell Line | 3 | 2020 | 15593 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 2018 | 4250 | 0.070 |
Why?
|
Chromosome Mapping | 2 | 2013 | 4622 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3526 | 0.070 |
Why?
|
Fertilization | 2 | 2007 | 198 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.070 |
Why?
|
Bone Morphogenetic Protein 15 | 2 | 2002 | 2 | 0.070 |
Why?
|
Growth Differentiation Factor 9 | 2 | 2002 | 3 | 0.070 |
Why?
|
Biological Evolution | 1 | 2012 | 1079 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2020 | 10464 | 0.070 |
Why?
|
Estrogen Receptor beta | 2 | 2005 | 171 | 0.060 |
Why?
|
Transfection | 1 | 2013 | 5758 | 0.060 |
Why?
|
Chromatography, Affinity | 2 | 2018 | 525 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2009 | 2911 | 0.060 |
Why?
|
Algorithms | 2 | 2017 | 14154 | 0.060 |
Why?
|
Host-Parasite Interactions | 1 | 2008 | 303 | 0.060 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2005 | 27 | 0.060 |
Why?
|
Lymph Nodes | 2 | 2015 | 3471 | 0.060 |
Why?
|
Genetic Variation | 2 | 2019 | 6606 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5857 | 0.060 |
Why?
|
Proteomics | 1 | 2019 | 3906 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2003 | 317 | 0.060 |
Why?
|
Computational Biology | 2 | 2016 | 3541 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2709 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2002 | 1658 | 0.060 |
Why?
|
Infertility | 1 | 2012 | 655 | 0.060 |
Why?
|
Cytoplasm | 3 | 2005 | 1500 | 0.060 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 866 | 0.060 |
Why?
|
Mass Spectrometry | 3 | 2018 | 2201 | 0.060 |
Why?
|
Microtubule Proteins | 1 | 2004 | 63 | 0.060 |
Why?
|
Databases, Genetic | 2 | 2022 | 1748 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1060 | 0.060 |
Why?
|
Retinoblastoma-Binding Protein 7 | 1 | 2003 | 3 | 0.060 |
Why?
|
DNA, Complementary | 2 | 2024 | 1992 | 0.060 |
Why?
|
Gonadotropins, Equine | 1 | 2003 | 7 | 0.060 |
Why?
|
Luteinizing Hormone, beta Subunit | 1 | 2003 | 11 | 0.060 |
Why?
|
Theca Cells | 1 | 2003 | 15 | 0.060 |
Why?
|
Centromere | 1 | 2004 | 215 | 0.060 |
Why?
|
Baltimore | 1 | 2024 | 234 | 0.060 |
Why?
|
Nucleoplasmins | 1 | 2003 | 5 | 0.050 |
Why?
|
Sertoli Cells | 1 | 2003 | 50 | 0.050 |
Why?
|
Proteome | 1 | 2013 | 1880 | 0.050 |
Why?
|
Morphogenesis | 1 | 2007 | 747 | 0.050 |
Why?
|
Castration | 1 | 2003 | 150 | 0.050 |
Why?
|
RNA, Double-Stranded | 2 | 2020 | 293 | 0.050 |
Why?
|
Mice, Mutant Strains | 2 | 2003 | 1755 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18358 | 0.050 |
Why?
|
Virus Replication | 1 | 2011 | 2458 | 0.050 |
Why?
|
Flutamide | 1 | 2003 | 95 | 0.050 |
Why?
|
Receptors, LH | 1 | 2002 | 18 | 0.050 |
Why?
|
Pituitary Gland | 2 | 2003 | 634 | 0.050 |
Why?
|
Integrin alpha6 | 1 | 2002 | 30 | 0.050 |
Why?
|
Estrogen Receptor alpha | 2 | 2005 | 580 | 0.050 |
Why?
|
Zygote | 1 | 2003 | 115 | 0.050 |
Why?
|
Granulosa Cell Tumor | 1 | 2003 | 77 | 0.050 |
Why?
|
Integrin alphaV | 1 | 2002 | 54 | 0.050 |
Why?
|
Receptors, FSH | 1 | 2002 | 29 | 0.050 |
Why?
|
Multigene Family | 2 | 2007 | 1082 | 0.050 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2023 | 168 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6876 | 0.050 |
Why?
|
Leucine Zippers | 1 | 2002 | 116 | 0.050 |
Why?
|
Integrin beta Chains | 1 | 2002 | 115 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6969 | 0.050 |
Why?
|
Ankyrins | 1 | 2002 | 123 | 0.050 |
Why?
|
Fallopian Tubes | 1 | 2023 | 179 | 0.050 |
Why?
|
Integrin beta3 | 1 | 2002 | 120 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2003 | 753 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1399 | 0.050 |
Why?
|
Receptors, Peptide | 1 | 2003 | 280 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20224 | 0.050 |
Why?
|
Mitosis | 2 | 2005 | 1190 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 161 | 0.050 |
Why?
|
Ligases | 1 | 2003 | 333 | 0.050 |
Why?
|
Chromatin | 2 | 2003 | 2967 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3794 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2022 | 363 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11914 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2003 | 458 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 322 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 367 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4069 | 0.040 |
Why?
|
Follistatin | 1 | 2001 | 138 | 0.040 |
Why?
|
Acetylation | 1 | 2003 | 1053 | 0.040 |
Why?
|
Growth Substances | 1 | 2002 | 761 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2002 | 577 | 0.040 |
Why?
|
Cell Nucleus | 2 | 2013 | 2887 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2004 | 632 | 0.040 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 542 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2017 | 1866 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2021 | 343 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2009 | 1713 | 0.040 |
Why?
|
Granzymes | 1 | 2021 | 278 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4785 | 0.040 |
Why?
|
Spectrum Analysis, Raman | 1 | 2022 | 244 | 0.040 |
Why?
|
Enzymes | 1 | 2001 | 254 | 0.040 |
Why?
|
Luteinizing Hormone | 1 | 2002 | 821 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 573 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2002 | 444 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2023 | 647 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2003 | 4940 | 0.040 |
Why?
|
Protein Biosynthesis | 2 | 2005 | 2094 | 0.040 |
Why?
|
Gene Frequency | 2 | 2020 | 3615 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.040 |
Why?
|
Research Personnel | 1 | 2024 | 590 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22292 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9563 | 0.040 |
Why?
|
Myeloid Progenitor Cells | 1 | 2019 | 112 | 0.040 |
Why?
|
Infertility, Female | 1 | 2005 | 765 | 0.040 |
Why?
|
Genotype | 3 | 2020 | 13038 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2023 | 1956 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2002 | 1163 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 9063 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 861 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4478 | 0.040 |
Why?
|
Mentors | 1 | 2024 | 672 | 0.040 |
Why?
|
Feedback | 1 | 2002 | 795 | 0.040 |
Why?
|
Adult | 11 | 2024 | 223622 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 4584 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 1019 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2003 | 731 | 0.040 |
Why?
|
Estradiol | 1 | 2005 | 1952 | 0.040 |
Why?
|
Erythroid Cells | 1 | 2019 | 238 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.040 |
Why?
|
Ubiquitin | 1 | 2003 | 843 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6404 | 0.040 |
Why?
|
Career Choice | 1 | 2024 | 769 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 808 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11254 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16027 | 0.040 |
Why?
|
Autoantigens | 1 | 2021 | 891 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1748 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9618 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 615 | 0.040 |
Why?
|
Viral Proteins | 1 | 2024 | 1802 | 0.030 |
Why?
|
Rats | 5 | 2005 | 23833 | 0.030 |
Why?
|
Melanoma | 1 | 2015 | 5705 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1408 | 0.030 |
Why?
|
Tretinoin | 1 | 2019 | 524 | 0.030 |
Why?
|
Middle Aged | 9 | 2019 | 223463 | 0.030 |
Why?
|
Steroids | 1 | 2001 | 936 | 0.030 |
Why?
|
Protein Kinases | 1 | 2003 | 1609 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2491 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2024 | 1218 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6808 | 0.030 |
Why?
|
Body Weight | 2 | 2003 | 4630 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18047 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2019 | 571 | 0.030 |
Why?
|
Genetics, Population | 1 | 2020 | 942 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 147 | 0.030 |
Why?
|
Cell Communication | 1 | 2002 | 1660 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 2004 | 1398 | 0.030 |
Why?
|
Color | 1 | 2016 | 297 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2019 | 832 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 1943 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1416 | 0.030 |
Why?
|
Leptin | 1 | 2002 | 1597 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
Pleural Effusion, Malignant | 1 | 2014 | 108 | 0.030 |
Why?
|
Glycoproteins | 1 | 2001 | 2204 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3612 | 0.030 |
Why?
|
Herpesviridae Infections | 1 | 2014 | 269 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2003 | 1902 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2009 | 22355 | 0.030 |
Why?
|
Cytogenetics | 1 | 2013 | 198 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 287 | 0.030 |
Why?
|
RNA Helicases | 1 | 2013 | 144 | 0.030 |
Why?
|
Herpesvirus 8, Human | 1 | 2014 | 256 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2661 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2050 | 0.030 |
Why?
|
Granulocyte Precursor Cells | 1 | 2012 | 49 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13646 | 0.020 |
Why?
|
Adolescent | 5 | 2019 | 89182 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2411 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2448 | 0.020 |
Why?
|
Maryland | 1 | 2012 | 277 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3079 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2007 | 2750 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2016 | 710 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2459 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2007 | 1704 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2007 | 7885 | 0.020 |
Why?
|
Activins | 2 | 2002 | 211 | 0.020 |
Why?
|
Mutation | 3 | 2024 | 30230 | 0.020 |
Why?
|
Esophagus | 1 | 2016 | 1042 | 0.020 |
Why?
|
Rats, Wistar | 2 | 2005 | 1890 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 30198 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13019 | 0.020 |
Why?
|
Phenotype | 3 | 2017 | 16716 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3064 | 0.020 |
Why?
|
Prognosis | 3 | 2017 | 30020 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2014 | 1082 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4526 | 0.020 |
Why?
|
Cysteamine | 1 | 2008 | 24 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2482 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3464 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11220 | 0.020 |
Why?
|
Arabidopsis | 1 | 2012 | 469 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2533 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1666 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2012 | 8562 | 0.020 |
Why?
|
Zona Pellucida | 1 | 2007 | 15 | 0.020 |
Why?
|
Aged | 6 | 2019 | 171544 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2924 | 0.020 |
Why?
|
Genome, Viral | 1 | 2011 | 673 | 0.020 |
Why?
|
Crystallization | 1 | 2008 | 523 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2012 | 877 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2823 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2012 | 863 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2008 | 491 | 0.020 |
Why?
|
Physicians | 1 | 2024 | 4614 | 0.020 |
Why?
|
Proestrus | 1 | 2005 | 14 | 0.020 |
Why?
|
Interferon Inducers | 1 | 2005 | 24 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2008 | 15854 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2002 | 3779 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2012 | 1780 | 0.020 |
Why?
|
Poly I-C | 1 | 2005 | 111 | 0.020 |
Why?
|
Chromosome Painting | 1 | 2004 | 26 | 0.020 |
Why?
|
Spermatids | 1 | 2004 | 36 | 0.010 |
Why?
|
Young Adult | 3 | 2019 | 60048 | 0.010 |
Why?
|
Trans-Activators | 1 | 2013 | 2855 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9346 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2013 | 59683 | 0.010 |
Why?
|
Tissue Donors | 1 | 2013 | 2389 | 0.010 |
Why?
|
Survival Rate | 2 | 2012 | 12870 | 0.010 |
Why?
|
Gonadotropins, Pituitary | 1 | 2003 | 69 | 0.010 |
Why?
|
Inhibin-beta Subunits | 1 | 2002 | 27 | 0.010 |
Why?
|
Transcription Factors | 1 | 2002 | 12166 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2433 | 0.010 |
Why?
|
Connective Tissue Growth Factor | 1 | 2002 | 91 | 0.010 |
Why?
|
Activin Receptors, Type II | 1 | 2003 | 123 | 0.010 |
Why?
|
Gonads | 1 | 2002 | 109 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2003 | 461 | 0.010 |
Why?
|
Hydroxamic Acids | 1 | 2004 | 482 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4031 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10863 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3436 | 0.010 |
Why?
|
CHO Cells | 1 | 2003 | 1380 | 0.010 |
Why?
|
Gene Library | 1 | 2003 | 1061 | 0.010 |
Why?
|
Gene Targeting | 1 | 2003 | 841 | 0.010 |
Why?
|
Nucleosomes | 1 | 2003 | 489 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2004 | 775 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1967 | 0.010 |
Why?
|
Cricetinae | 1 | 2003 | 2423 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2002 | 637 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2524 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2298 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2002 | 1468 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21163 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2005 | 6132 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2001 | 566 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5993 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 5033 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2003 | 936 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8072 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1320 | 0.010 |
Why?
|
Models, Animal | 1 | 2003 | 2124 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6238 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39405 | 0.010 |
Why?
|
United States | 1 | 2004 | 73144 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4209 | 0.010 |
Why?
|
Gene Deletion | 1 | 2003 | 2673 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2002 | 11659 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81768 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8326 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2889 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3692 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5796 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2008 | 4300 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65365 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 3722 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10266 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36512 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42654 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 19019 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9494 | 0.000 |
Why?
|
Child | 1 | 2012 | 80894 | 0.000 |
Why?
|
Time Factors | 1 | 2002 | 40267 | 0.000 |
Why?
|